Atlas Trials

Risdiplam in Patients With Spinal Muscular Atrophy Previously Treated With Nusinersen

Clinical trial NCT05522361 · UNKNOWN

Trial details

NCT number
NCT05522361
Sponsor
Clinic for Special Children
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Spinal Muscular Atrophy
Start date
2022-11-06
Primary completion
2025-12-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.